Chronic fatigue syndrome progression and self-defined recovery: Evidence from the CDC surveillance system

Journal of Chronic Fatigue Syndrome

Volumn 5, Issue 1, 1999, Pages 17-27

  Reyes, Michele ^a,c   Dobbins, James G ^a   Nisenbaum, Rosane ^a   Subedar, Nazerah S ^a   Randall, Bonnie ^b   Reeves, William C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ABT ASSOCIATES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

CFS course of illness; Natural history; Recovery; Symptoms

Indexed keywords

ARTICLE; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; REMISSION; SELF REPORT; SYMPTOM;

EID: 6544244601     PISSN: 10573321     EISSN: None     Source Type: Journal    
DOI: 10.1300/j092v05n01_03     Document Type: Article

References (24)

1. McCluskey DR, Riley MS. Chronic Fatigue Syndrome. Compr Ther 1992; 18:13-6.
2. Behan PO, Bakheit AO. Clinical Spectrum of Postviral Fatigue Syndrome. Br Med Bull 1991;47:793-808.
3. Bell DS. The Doctors Guide to Chronic Fatigue Syndrome. Reading, MA: Addison Wesley, 1994. p.138.
4. Mildon CA. Clinical Observations of Chronic Fatigue Syndrome. Can Dis Wkly Rep 1991;17 Suppl 1E:17-9.
5. Ho-Yen DO. Patient Management and the Post Viral Fatigue Syndrome. Br J Gen Pract 1990;40:82-3.
6. Fukuda K, Gantz NM. Management Strategies for Chronic Fatigue Syndrome. Federal Practitioner 1995;12-27.
7. Joyce J, Hotopf M, Wessely S. The Prognosis of Chronic Fatigue and Chronic Fatigue Syndrome: A Systematic Review. QJM 1997;90:223-33.
8. Wilson A, Hickie I, Lloyd A, et al. Longitudinal Study of Outcome of Chronic Fatigue Sy ndrome. Br Med J 1994;308:756-9.
9. Bombardier CH, Buchwald D. Outcome and Prognosis of Patients with Chronic Fatigue vs. Chronic Fatigue Syndrome. Ann Intern Med 1995;155:2105-10.
10. Peterson PK, Schenck CH, Sherman R. Chronic Fatigue Syndrome in Minnesota. Minn Med 1991;74:21-6.
11. Vercoulen JH, Swanink CM, Fennis JF, et al. Prognosis in Chronic Fatigue Syndrome: A Prospective Study on the Natural Course. J Neurol Neurosurg Psychiatry 1996;60:489-94.
12. Reyes M, Gary HE, Dobbins JG, et al. Surveillance for Chronic Fatigue Syndrome-Four US Cities, September 1989 through August 1993. MMWR 1997;47:1-15.
13. Holmes GP, Kaplan JE, Gantz NM, et al. Chronic Fatigue Syndrome: A Working Case Definition. Ann Intern Med 1988;108:387-9.
14. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994; 121:953-9.
15. Selvin S. Statistical Analysis of Epidemiologic Data. New York: Oxford University Press, 1996, pp. 311-55.
16. Smith DP. User's Guide for Program SURVIVAL 4.1. Houston, TX: University of Texas School of Public Health, 1995.
17. Zeger SL, Liang KY, Albert PS. Models for Longitudinal Data: A Generalized Estimating Equation Approach. Biometrics 1988;44:1049-60.
18. Buchwald D, Umali P, Umali J, et al. Chronic Fatigue and the Chronic Fatigue Syndrome: Prevalence in a Pacific Northwest Health Care System. Ann Intern Med 1995;123:81-8.
19. Ray C, Jefferies S, Weir WR. Life-Events and the Course of Chronic Fatigue Syndrome. Br J Med Psychol 1995;68:323-31.
20. Bates DW, Schmitt W, Buchwald D, et al. Prevalence of Fatigue and Chronic Fatigue Syndrome in a Primary Care Practice. Arch Intern Med 1993;153:2759-65.
21. Wessely S, Chalder T, Hirsch S, et al. The Prevalence and Morbidity of Chronic Fatigue and Chronic Fatigue Syndrome: A Prospective Primary Care Study. Am J Public Health 1997;87:1449-55.
22. Clark MR, Katon W, Russo J. et al. Chronic Fatigue: Risk Factors for Symptom Persistence in a 2 1/2-Year Follow-Up Study. Am J Med 1995;98:187-95.
23. Tirelli U, Marotta G, Improta S. Immunological Abnormalities in Patients with Chronic Fatigue Syndrome. Scand J Immunol 1994;40:601-8.
24. Bonner D, Ron M, Chalder T, et al. Chronic Fatigue Syndrome: A Follow-Up Study. J Neurol Neurosurg Psychiatry 1994;57:617-21.